Marinus Pharmaceuticals, Inc. earnings per share and revenue

MRNS earnings per share for the last quarter are -0.42 USD whereas the estimation was -0.41 USD which accounts for -2.64% surprise. Company revenue for the same period amounts to 8.54 M USD despite the estimated figure of 9.42 M USD. Estimated earnings per share for the next quarter are -0.29 USD, and revenue is expected to reach 11.40 M USD. Also watch annual changes over time to get a bigger picture of MRNS earnings per share and revenue dynamics.